About us

We are united in our mission to deliver patient-needed therapies sooner.

We are curious, bold, and share a passion for thinking differently.

Diverse Portfolio

SMPA is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies.

Our Origins

SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc., and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company.

Our parent company, Sumitomo Pharma Co., Ltd., was established in 1897 and has an extensive history of supporting health and wellbeing. Sumitomo Pharma is a member of the Sumitomo Group, which has a history of about 400 years. Learn more about Sumitomo Pharma’s history here.

Our Team

We are industry-leading experts in drug development, business, engineering, science, and technology. Together, we operate with data-driven insights, agility, and scientific rigor to deliver the therapies that people need most.


Photograph of Tsutomu Nakagawa, Chief Strategy Officer.
Tsutomu Nakagawa, Ph.D.
President & Chief Executive Officer
Photograph of Adele Gulfo, Chief Executive Officer of Biopharma Commercial Unit.
Adele Gulfo, MBA
Chief Executive Officer of Biopharma Commercial Unit
Photograph of Jatin Shah, Chief Medical Officer - Oncology.
Jatin Shah, M.D.
Chief Medical Officer - Oncology
Photograph of Andrew Hetherington, Chief Technology & Quality Officer.
Andrew Hetherington, MBA
Chief Technology & Quality Officer
Photograph of Yumi Sato, Chief Development Officer.
Yumi Sato
Chief Development Officer
Photograph of Betzy Estrada, Chief Human Resources Officer.
Betzy Estrada
Chief Human Resources Officer
Photograph of Tara Soni, Chief Legal Officer.
Tara Soni
Chief Legal Officer
Photograph of Ron Gimbel, Chief Financial Officer.
Ron Gimbel
Chief Financial Officer

Board of Directors

Photograph of Yumi Sato, Member, Board of Directors, Chief Development Officer, Sumitomo Pharma America, Inc.
Yumi Sato
Member, Board of Directors, Chief Development Officer, Sumitomo Pharma America
Photograph of Ron Gimbel, Chief Financial Officer.
Ron Gimbel
Member, Board of Directors, Chief Financial Officer, Sumitomo Pharma America

Our Reach

Global reach with an expansive U.S. footprint

SMPA is part of a global ecosystem of companies working on innovative research and development activities to transform healthcare and improve the lives of people worldwide. This global ecosystem has a geographic footprint spanning Japan, the U.S., China, Canada, and Europe as well as talent, knowledge, and resources across a wide spectrum of technologies and therapeutic areas.

Contact Us

Illustration of map of USA and Switzerland featuring cities for the locations that Sumitomo Pharma America operates.